// App-Quantinova.ai

611 : High-plex proteomic prognostic marker discovery for patients with pancreatic cancer adenocarcinoma using digital spatial profiling.

Researchers

Presenter

  • Nigel Balfour Jamieson

Principal Investigators

  • Assya Legrini

  • Holly Leslie

  • Stephan Dreyer

  • Andrew V Biankin

  • David Kuang-Fu Chang

Medical Centers

  • Wolfson Wohl Cancer Research Centre, Institute of Cancer Sciences, University of Glasgow, Glasgow, United Kingdom

  • University of Glasgow, Glasgow, United Kingdom

  • Wolfson Wohl Cancer Research Centre, Institute of Cancer Sciences, University of Glasgow, Glasgow, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Pancreatic cancer

  • Microphthalmia, syndromic, 9

Biomarkers

  • Cluster of Differentiation 2AP

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved